Aktive Positionen von Alison V. Todd
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Technik-/Wissenschafts-/F&E-Leiter | 08.06.2011 | - |
Gründer | 08.06.2011 | - |
Karriereverlauf von Alison V. Todd
Ehemalige bekannte Positionen von Alison V. Todd
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Johnson & Johnson Research Pty Ltd. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Alison V. Todd
The University of Sydney | Doctorate Degree |
Statistik
International
Australien | 3 |
Japan | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Johnson & Johnson Research Pty Ltd. | |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
- Börse
- Insiders
- Alison V. Todd
- Erfahrung